TReP-132 Is a Novel Progesterone Receptor Coactivator Required for the Inhibition of Breast Cancer Cell Growth and Enhancement of Differentiation by Progesterone

Molecular and Cellular Biology - United States
doi 10.1128/mcb.00326-06
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology


Related search